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We analyse the growth of corporate R&D in the Spanish manufacturing sector through its 
decomposition into the extensive and intensive margins. These margins are decomposed into three 
distinct components: starting new R&D activities; R&D activities that survive or persist; and deepening 
existing R&D efforts. The data used is a panel of Spanish manufacturing firms drawn from the Encuesta 
sobre Estrategias Empresariales, for the period 1990-2006. We show that despite having experienced a 
substantial increase in R&D, the relative importance of each component differs for small and large 
firms. We find that small firms would have had a significant higher R&D growth should they be able to 
improve their performance with respect to the survival component of the intensive margin. For large 
firms, deepening appears to be the most important component explaining R&D in the long run. 
Keywords: R&D; Extensive margins; Intensive margin. 
JEL classification: O3 
Resumen 
Este trabajo estudia el crecimiento del gasto privado en I+D de las empresas manufactureras españolas a 
través de su descomposición en dos componentes: el margen extensivo y el margen intensivo. Estos 
márgenes se descomponen en 3 sub-componentes: iniciarse en la realización de nuevas actividades de 
I+D; supervivencia o persistencia en la realización de actividades de I+D; e,  intensificación de las 
actividades de I+D ya existentes.  Los datos que utilizamos en este trabajo han sido extraídos de la 
Encuesta sobre Estrategias Empresariales, para el periodo 1990-2006. Nuestros resultados indican que a 
pesar de que las empresas manufactureras españolas han experimentado un importante aumento en el 
gasto en I+D, la importancia relativa de cada componente es distinta para las empresas pequeñas 
respecto de las empresas grandes. Así, las empresas pequeñas hubieran experimentado un mayor 
aumento en el crecimiento del gasto en I+D si hubieran sido capaces de mejorar el componente de 
persistencia en la realización de actividades de I+D, dentro del margen intensivo. Para las empresas 
grandes, la intensificación en la realización de actividades de I+D constituye el principal componente a 
la hora de explicar la evolución de largo plazo del gasto en I+D. 
Palabras clave: I+D; Margen extensivo; Margen intensivo. 
Clasificación JEL: O3 
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31. Introduction 
The importance of investment in research and development (R&D) for a country’s long-term 
rate of economic growth has received increasing attention both from researchers and policy-
makers. Indeed, increasing R&D intensity is an issue of major concern for long-term 
European policy strategy. In 2000 the European Union launched the Lisbon Agenda, an 
ambitious strategy which aimed at making Europe the most dynamic knowledge economy by 
2010. Two years later, in the spirit of the Lisbon strategy, the EU members set the “Barcelona 
target”, a compromise to increase Europe’s expenditure on R&D to 3% of GDP by 2010, two 
thirds of which should come from the private sector. However, European countries are far 
from the Barcelona target (OECD, 2008). On average, the EU27 spent on R&D just 1.83% of 
GDP in 2006, with Spain lagging significantly behind with only 1.2%. However, regardless of 
the very limited progress towards this target, the European Council ratified it in 2010 as one 
of the headline objectives of the Europe 2020 strategy. Notwithstanding the low R&D 
investment rates, Spain has experienced a substantial increase in R&D expenditure since the 
mid-1990s. This study aims to analyse the main components of these changes in corporate 
R&D expenditures for the Spanish industry and to inform innovation policy on possible 
channels to attain, or at least to converge, to the “Barcelona target”. 
The recent availability of disaggregated data at firm level has increased the interest in 
a more careful accounting of changes in patterns of corporate R&D investment. In particular, 
the aim of this study is to analyse the growth of private R&D investment in the Spanish 
manufacturing sector through the decomposition into extensive and intensive R&D margins. 
The extensive margin refers to the evolution of R&D expenditure capturing the number of 
firms that start performing R&D (i.e. new firms with positive R&D expenditure). Whereas the 
intensive margin can be decomposed into two distinct parts: (i) established R&D activities 
that survive or persist; and, (ii) deepening existing R&D activities (intensifying the R&D 
investment effort by existing R&D performers). Starting new R&D activities (i.e. extensive 
margin) is the motivation behind many R&D promotion policies. However, such policies 
might in many occasions be of limited value as, in general, it is the intensification of R&D 
activities (i.e. the intensive margin) what reports the highest pay-offs in terms of inventions, 
patents or other output measures of innovation.  
Previous literature analysing the distinction between intensive and extensive margins 
has focused mainly on volumes of trade (Besedes and Prusa, 2007) or on the adoption of new 
technology (Comin et al., 2006), neglecting the decomposition for R&D investment. 
Moreover, the analysis of the survival and deepening components of the intensive margin are 
seldom distinguished in the literature. Existing research has focused only on changes in R&D 
investment and the number of firms undertaking R&D activities over time and implicitly 
considering only R&D deepening without taking into account the issue of survival of R&D 
performers. In this paper, we investigate that not accounting for this component may have 
consequences in the analysis of R&D expenditure and in its policy implications. This 
assertion is based on our following hypothesis: 
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Hypothesis 1: We expect R&D expenditures to be relatively low the first years for a 
new R&D spell and increase with the duration of the spell. We define an R&D spell as 
the number of years for which a firm continuously performs R&D activities (i.e., it has 
a positive R&D expenditure). 
Hypothesis 2: The probability of failure of R&D spells decreases with the length of 
the spell (Máñez et al. 2009b) 
These two hypotheses imply that increases in the intensive margin are only possible 
for those firms with high survival rates; otherwise we would not observe deepening of the 
R&D expenditures. In other words, we are assuming that deepening is conditional on survival. 
Further, higher survival rates would result in higher R&D expenditure growth even in the 
absence of deepening. And, the R&D activities embodied in failures dampen a country’s 
overall R&D expenditure growth. Finally, the assumption of a constant failure rate across 
years and different technological industries is generally rejected by the data. By focusing just 
on the total number of firms engaged in R&D activities might overlook the role of R&D 
activity survival. 
The aim of this research is to study the growth of R&D expenditure for Spanish 
manufacturing, applying the extensive and intensive margin decomposition approach to gain 
insight in the role played by these different components. To conduct our research we use a 
representative sample of Spanish manufacturing firms drawn from the Encuesta sobre 
Estrategias Empresariales (ESEE) for the period 1990-2006. Given the size of our database, 
we will analyse intensive and extensive margins by groups of industries, using as grouping 
criterion the technological intensity (high, medium and low tech industries). This study 
represents the first attempt, using a panel dataset of Spanish firms, to analyse the relative 
importance of the extensive and intensive margins in explaining corporate R&D growth.  
The rest of the paper is organized as follows. Section 2 provides a review of previous 
literature on the intensive and intensive margins. Section 3 describes the data and comments 
on the representativeness of the sample. Section 4 provides some preliminary evidence of the 
intensive and extensive margins.  The methodology used to decompose R&D growth is 
outlined in Section 5. Section 6 presents the main results relating to the intensive and 
extensive margins and their relative importance. Section 7 offers some concluding comments. 
2. Related Literature 
The relative importance of the extensive versus the intensive margin has been an issue of 
considerable debate in the international trade literature (Besedes and Prusa, 2007). Though 
there are studies that emphasize the importance of extensive margins in explaining the growth 
of trade volumes (Hummels and Klenow, 2005), numerous recent studies highlight the 
important role played by the intensive margin (Bernard et al., 2009; Besedes and Prusa, 2007; 
Brenton and Newfarmer, 2007; and Helpman et al., 2008). That is, the growth of trade comes 
primarily from existing trade flows rather than from new trade flows.  
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The distinction between the intensive and extensive margin has also received attention 
in the literature of adoption and diffusion of new technology (Comin et al., 2006, and Battisti 
et al., 2009). In this literature, the extensive margin relates to the spread of first use of a new 
technology across countries, industries or firms. On the other hand, the intensive margin 
relates to the extent to which the technology is used within countries, industries or firms. 
These studies also stress the importance of the intensive margin in explaining the growth of 
technological usage. In particular, Battisti et al. (2009) conclude that to achieve further usage 
of e-business, firms should concentrate upon greater depth (intensive margin) rather than 
greater breath (further spreading of basic usage). 
Despite the number of studies looking at the distinction between intensive and 
extensive margin, the survival and deepening components of the intensive margins have been 
seldom analysed. In particular, existing research has focused mainly on the deepening 
component of the intensive margin without considering the issue of survival. Besedes and 
Prusa (2007) claim that this omission is not without consequence given that survival is a 
necessary condition for deepening and that longer survival would result in higher growth even 
in the absence of deepening. 
Regarding the study of R&D growth, existing research has focused on changes in 
R&D investment driven by the number of firms undertaking R&D activities over time and 
implicitly considering only R&D deepening without taking into account the issue of survival 
of R&D performers in an integrated approach. Though economic theory emphasises that 
innovation is inherently a dynamic process between heterogeneous firms (Blundell et al., 
1995), firm level empirical evidence on the persistence in R&D activities is rather scarce
1. 
Particularly, persistence in innovation have been studied from the output side of the 
innovation process
2
Among the other things highlighted this review makes clear that there is no prior study 
that tries to integrate the different aspects of the extensive and intensive margin in order to 
explain corporate R&D growth. Therefore, this will be our aim in this study.  
, however few studies have paid attention to the input side, i.e. to the 
persistence in R&D activities (the exceptions being Máñez et al., 2009a, 2009b; and Peters, 
2009). These studies found that R&D behaviour is persistent at the firm level to a very large 
extent and that innovation persistence is technology specific. Using survival techniques, 
Máñez  et al. (2009b) focus exclusively on the determinants of the survival of R&D 
performers. They find that R&D capital is an important driver of R&D persistence and that 
firm’s R&D spells exhibit negative duration dependence, indicating that the probability that a 
firms stops doing R&D decreases as the performance of R&D continues. 
                                                 
1 There are several theoretical reasons that may explain persistence in innovation: learning effects (Rosemberg 
1976); a success-breeds-success process (Mansfield 1968) or the existence of R&D costs (Sutton 1991). For a 
more detailed explanation see Máñez et al. (2009a, 2009b). 
2 The results on the output side are inconclusive. While studies using patents found low levels of persistence 
(Cefis 2003; Geroski et al. 1997), those using innovation counts obtain mixed findings: on one hand Duguet and 
Monjon (2004) and Rogers (2004) find high persistence, but on the other hand Geroski et al.  (1997) and 
Raymond et al. (2006) could not ascertain innovation persistence for UK and Dutch manufacturing firms. 
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3. Data 
The data used in this paper are drawn from the Encuesta Sobre Estrategias Empresariales 
survey (ESEE), for the period 1990-2006. This survey, sponsored by the Ministry of Industry, 
is conducted yearly since 1990 (for more details on the survey, see, for example, Fariñas and 
Jaumandreu, 1999). The ESEE is representative of Spanish manufacturing firms classified by 
industrial sectors and size categories and provides exhaustive information at the firm level, 
including R&D expenditures. The sampling scheme is as follows. Manufacturing firms with 
less than 10 employees are excluded from the survey. Firms with 10 to 200 employees are 
randomly sampled by industry (at two-digit NACE level) and size, holding around a 5% of 
the population in 1990. All firms with more than 200 employees are requested to participate, 
obtaining a participation rate around 70%. The ESEE survey is an unbalanced panel given 
that some firms exit the market, shift to non-manufacturing activities or leave the survey. 
Important efforts have been made to minimise attrition and to annually incorporate new firms 






In Table 1 we summarize the sample used, the percentage of employment, sales and R&D 
expenditure, for large and small firms in the 1990 complete sample and in the continuing 
sample.
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Table 1. Sample representativeness: large versus small firms, 1990 
 Comparing these two samples we see that small firms are overrepresented in our 
sample (with respect to the complete sample in 1990) in terms of proportion of firms, 
employment sales and R&D expenditure. However, if we focus on the sample of firms (both 
large and small) performing R&D, see Table 2, and compare them with the sample of firms 
that do not perform R&D, we get that for small firms both the complete and the continuing 
samples provide very similar results in terms of percentage of firms, size, R&D expenditures 
over sales, sales and employment. For large firms we see that both the proportion of firms and 
the R&D expenditure over sales are quite similar for both samples but the figures differ in 
terms of size, sales and employment.  
  1990 complete sample  Continuing sample 1990 
Averages   Small firms  Large firms  Small firms  Large firms 
Number of firms  1478  710  301  103 
% of total sample   67.55%  32.45%  74.50%  25.50% 
% of total employment  9.42%  90.58%  16.11%  83.88% 
% of total sales  6.95%  93.05%  11.80%  88.20% 
% of total R&D 
expenditure 
3.90%  96.10%  13.36%  86.64% 
                                                 
3 See http://www.funep.es/esee/ing/i_esee.asp for further details. 
4 We will use the sample of continuing firms, which means firms that are in operation and do not suffer any 
process of merger, acquisition or other from 1990 to 2006. 
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Table 2. Sample representativeness: R&D firms versus non-R&D firms, 1990  
  1990 complete sample  Continuing sample 1990 
Averages  Non-R&D 
Firms 
R&D firms  Non-R&D 
Firms 
R&D firms 
1. Small firms          
Number of firms  1215  249  256  45 
% of total sample  82.99%  17.01%  85.05%  14.95% 
Average size (employees)  32.64  66.65  29.56  63 
R&D expenditure/Sales (average)   0%  4.42%  0%  2.93% 
% of total sales  67.55%  32.45%  67.69%  32.31% 
% of total employment  70.50%  29.50%  73.01%  26.99% 
2. Large firms         
Number of firms  225  472  39  64 
% of total sample  31.78%  68.22%  37.86%  62.14% 
Average size (employees)  506.30  900.95  653.89  456.32 
R&D expenditure/Sales (average)
  0%  1.96%  0%  1.32% 
% of total sales  19.31%  80.68%  58.27%  41.72% 
% of total employment  21.13%  78.87%  46.61%  53.38% 
Finally, in Table 3 we report the proportion of firms in low, med and high tech 
industries, both for small and large firms, for the complete sample in 1990 and the continuing 
sample.
5
Therefore, we consider that the sample we use to carry out our analysis is comparable 
to the complete sample for small firms in most of the aspects we analyse and has some 
differences for large firms, although we get comparable figures for the variables of interest 
(size and R&D expenditure over sales).
 For small firms we obtain very similar proportions while for large firms only the 
percentage of firms in low-tech industries is similar across samples, being the firms operating 
in med-tech industries overrepresented in our sample and the firms operating in high-tech 
underrepresented. 
6
Table 3. Sample representativeness by size and technological sector, 1990 
 
  Low-tech  Med-tech  High-tech 


















Small firms             
  885  180  368  82  225  39 
  59.80%  59.80%  24.90%  27.24%  15.22%  12.96% 
Large 
firms 
           
  285  45  223  39  202  19 
  40.14%  43.69%  31.41%  37.86%  28.45%  18.45% 
             
                                                 
5 See the Appendix for the classification of industries in the three technological groups. 
6 Using the continuing sample we avoid the issue of firms that stop collaborating with the survey.  
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A key step in our analysis involves converting the annual data into spells of R&D 
activity. We define an R&D spell as the number of years for which a firm continuously 
performs R&D activities (i.e., it has a positive R&D expenditure).
7
4. Extensive and Intensive Margins 
 
4.1. Extensive Margin 
We define the extensive margin as the number of new firms doing R&D in each technological 
sector. An industry can experience a change in its extensive margin if a firm that had not 
previously done R&D, starts performing R&D activities. We begin by providing summary 
statistics about the growth in corporate R&D, for small and large firms operating in low, med 
and high-tech industries. The first column in Table 4 shows the growth of aggregate R&D (in 
real terms) or each type of industry (high, medium and low-tech). The second column shows 
the growth in number of new firms doing R&D.  We can see that the growth of R&D 
expenditure (which is related to the intensive margin) is always higher than the growth of 
R&D firms (more related to the extensive margin). Firms operating in the low-tech sector 
experience the largest gains in the growth of R&D firms. As regards to size, small firms 
experience larger gains in the growth of firms performing R&D,
8 however large firms have a 
higher growth in R&D expenditure on average.
9
Another interesting descriptive statistic is the realized potential number of firms 
performing R&D. The maximum potential number is 100%. In columns 3 and 4 of Table 4 we 
report the maximum potential number of firms that can perform R&D activities both in 1990 
(starting period of our sample) and in 2005 (final period). The figures in columns 3 and 4 
reveal that, on average, only 14.95% of small firms perform R&D activities in 1990 and this 
figure rises to 19.93% in 2005. For large firms we observe that 63.11% of firms performed 
R&D activities in 1990 and 67.96% in 2005. Inspecting these figures by technological sector 
we find that the proportion of small firms performing R&D activities, both in 1990 and in 
2005, increases significantly from low to high-tech sectors. For large firms this is not 
completely so as in 2005 the proportion of large firms performing R&D activities was larger 
in the med-tech sector than in the high-tech sector. For each technological sector and size 
group (except for large firms operating in high-tech sectors) we observe an increase in the 
potential number of R&D performers although there is still scope for gain, specially for small 
firms for which only 20% of them perform R&D activities (this proportion for large firms is 
around 68%). In summary, although firms have made an effort from 1990 to 2005 to 
undertake R&D activities, there are still many firms (especially among small firms) that do 
not perform these activities.  
  
                                                 
7 In this research we are not able to solve the problem of left- censoring in the spells. 
8 This conclusion is true for low, med and high-tech industrial sectors. 
9 Large firms operating in med-tech industries mainly drive this result, as the growth of R&D expenditure for 
small firms operating in low and high-tech industries is larger that the corresponding figures for large firms. 
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In the last two columns we investigate further the extensive margin. Thus, in column 5 
we report the average number of firms that are in their initial year performing R&D, over the 
total number of firms performing R&D. We detect that the extensive margin is always greater 
for small firms (20.51% and 6.86% on average for small and large firms, respectively). The 
difference between small and large firms is especially relevant in low and me-tech industries 
where the small firms’ extensive margin is around 25%. This suggests that the extensive 
margin may play an important role explaining R&D growth for small firms but does not seem 
to be so relevant for large firms.  
Table 4. R&D and extensive margin growth rates, 1990-2005 





















  (1)  (2)  (3)  (4)  (5)  (6) 
Total              
Small firms  4.83%  1.80%  14.95%  19.93%  20.51%  8.00% 
Large firms  11.71%  0.46%  63.11%  67.96%  6.86%  1.13% 
Small firms             
Low-tech firms  8.77%  3.37%  7.78%  13.33%  25.27%  10.66% 
Med-tech firms  0.39%  0.83%  17.07%  19.51%  25.47%  10.67% 
High-tech firms  6.29%  1.02%  43.59%  51.28%  7.97%  2.36% 
 Large firms             
Low-tech firms  3.86%  2.20%  42.22%  60.00%  10.64%  5.73% 
Med-tech firms  18.52%  0.00%  76.92%  76.92%  4.63%  0.35% 
High-tech firms  1.89%  -1.30%  84.21%  68.42%  4.17%  1.52% 
Note: 1993 represents 99.51% of total R&D by new entrants and in 1998 represents a 97.53%. 
In column 6 we present a weighted measure of the size of the extensive margin, where 
we use R&D expenditure to weight the extensive margin. The general pattern we observe is 
comparable to that observed in column 5, however these two columns differ in that R&D 
expenditures for new firms performing R&D are considerably smaller than those for firms 
that perform R&D on continuous basis. Thus we get, as one would expect, that new R&D 
performers invest less in R&D than established R&D performers. This evidence reinforces the 
idea that new R&D firms can only have a significant impact on the aggregate R&D growth of 
a country if they survive and deepen, as in their initial years the R&D expenditure is too small 
to have a significant effect on the overall R&D expenditure growth. 
 
4.2. Intensive Margin 







In a given calendar period, we find different lengths for the R&D spells: some firms perform 
R&D for a long period in a continuous basis, while others do so for a short period. Thus in the 
same period different firms are active in R&D for different number of years, and the 
distribution of duration reflects the longevity of active relationships. The duration in 
performing R&D is most appropriately summarised using survival analysis. We estimate the 
Kaplan-Meier survival function both for large and small firms and for low, med and high-tech 
sectors. We plot these graphs in Figures 1, 2 and 3.  
In figure 1 we plot the survival distribution for large and small firms. From the 
inspection of figure 1 we can conclude that the survival function for small and large firms is 
very different.
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In figure 2 we plot the survivor functions for small firms disaggregated by 
technological sector (either low, med or high-tech sectors). We observe two different patterns 
in terms of survival: on the one hand, we observe that small firms operating in med and low-
tech industries have a short R&D spell duration, the median survival time is 2 years for these 
firms, and on the other hand we have firms operating in high-tech industries which have a 
much longer R&D spell duration, with the median duration time being 11 years. Further, 
more than 45% of the R&D spells for firms operating in high-tech industries are still alive 
after 16 years, while this figure is around 10% for firms operating in low and med-tech 
industries. We test for equality of survivor functions and reject the null hypothesis of equality 
of the three functions.
  Further, duration of R&D spells is remarkably short for small firms as 
compared with large firms. The median survival time is 2 years for small firms, while it is 11 
years for large firms. That is, within small firms 50 per cent of R&D spells fail in the first two 
years. Further, 50% of the R&D spells for large firms are still in function after 12 years 
whereas only 20% of the R&D spells for small firms are still in operation after 12 years. After 
16 years, 45% of R&D spells for large firms are still alive but only 15% of the R&D spells 
survive within small firms. Therefore, large firms perform better than small firms in terms of 
survival or R&D spells. This high failure rate for small firms points out that when analysing 
the R&D growth rate we should be cautious to attributing gains along the extensive margin. 
This survival analysis reveals that increases in the extensive margin for small firms in a given 
year will disappear within few years. The above conclusion does not hold for large firms, as 
the R&D spell survival is much longer. 
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Finally, in figure 3 we plot the corresponding survivor functions for large firms across the 
three technological sectors. As shown, the R&D spell patterns for large firms are different to the 
ones obtained for small firms. The three survivor functions are very similar and we cannot reject 
  
                                                 
10 We test (using log-rank test) for equality of survivor functions. We reject the null hypothesis of equality with a 
χ =
2 32.79 and a p-value=0.000).
 
11 We reject the null hypothesis of equality with a  χ =
2 16.00  and a p-value=0.000.  
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the null hypothesis of equality.
12
Figure 1. R&D spells survivor functions by size, 1990-2005 
 However, the median duration time of spells changes across 
technological sectors: it is 5, 10 and 16 years for firms in low, high and med-tech industries, 
respectively. It is interesting to observe that large firms operating in med-tech industries enjoy the 
highest median survival rates. In any case, the results confirm that innovation persistence is a 
characteristic of large firms and, irrespectively of size, of high-tech sectors. 
 
 
Figure 2. R&D spell survivor functions for small firms by technological sector, 1990-2005 
 
                                                 
12 We cannot reject the null hypothesis of equality with a  χ =
2 3.35  and a p-value=0.187. 
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Figure 3. R&D spell survivor functions for large firms by technological sector, 1990-2005 
 
Deepening 
The examination of the survival component indicates that many small firms do not have an 
opportunity to deepen their R&D efforts given their early failure. To analyse the deepening 
component we are going to focus, particularly, on the long term relationships, by which we 
mean those R&D spells that continue for the entire period since 1990 to 2005.  
Columns 1 to 3 of Table 5 characterize the long term deepening component of R&D. 
As discussed previously, small firms –particularly in low and med tech industries- are unable 
to continue doing R&D in the long term. This fact is also reflected in column 1, which reports 
the fraction of R&D spells in 2005, which were active in 1990. While 66% of large firms that 
did R&D in 1990 still continue persistently doing R&D in 2005; only 29% of small firms 
remain active. If we look at sectoral level, the differences between large and small firms are 
still more notorious with the exception of high tech industries, where the differences are less 
pronounced. For instance, in the case of low tech sectors we find that 63% of large firms 
continue persistently doing R&D for the whole period while only 7% of small firms do so. 
Looking at column 2 we observe that long term relationships embody the majority of R&D 
value. Large firms, especially those in med tech and high tech sectors have more than 90% of 
their 2005 R&D value embodied in the long term relationship. Small firms in the med-tech 
sector have the lowest percentage of their 2005 R&D value in long term relationship at 36%, 
followed by small firms in low-tech sectors. High failure rates and low fractions of R&D 
value embodied in long term spells suggest an important role of survival for R&D growth in 
small firms, with the only exception of small firms in high tech sectors. The results imply that 
small firms have a larger share of their R&D embodied in short term R&D activities which 
are more likely to fail, given that few of them persist doing R&D over the long term.   
13 
Column 3 examines average annual deepening of long term relationships. 
Independently of size, we observe that R&D long term performers in med tech industries 
deepen at a faster rate than those in other sectors, particularly in low tech sectors. Overall, 
small firms deepen at lower rates than large firms, with a larger difference in the high tech 
industries in which the deepening rates are 5.7% for large and 2.55 % for small firms.  
Columns 4 and 5 provide a different perspective of the deepening component. We 
obtain deepening rates for spells of 5 and 10 years respectively. In other words, these figures 
represent the annual average growth rate of R&D value for firms doing continuously R&D 
over at least 5 and 10 years respectively. Comparing with the results for the long terms spells 
we observe that the deepening rate increases with the number of periods doing R&D. Overall, 
the deepening rate is 3.34% (-1.01%) for large (small) firms doing R&D for at least 5 years, 
5.06% (4.24%) for firms doing R&D for at least 10 years, and 5.69% (4.34%) for the long 
term R&D performers. Interestingly, the value of R&D for spells of at least 5 years decreases 
in the case of small firms, due to the decrease in med tech small firms. For longer spells, we 
always observe positive deepening rates. Additionally, we observe similar patterns than in the 
analysis of long term spells, i.e. independently of the technological sector, small firms deepen 
at lower rates than large firms. 
Table 5. Deepening in performance of R&D, 1990-2005 
  Long term spells  R&D value (average growth) 











For spells of 
at least 5 
years of 
duration 
For spells of 
at least 10 
years of 
duration 
  (1)  (2)  (3)  (4)  (5) 
Total           
Small firms  28.88%  56.33%  4.34%  -1.01%  4.24% 
Large firms  66.15%  95.50%  5.69%  3.34%  5.06% 
Small firms           
Low-tech firms  7.14%  54.82%  2.22%  2.20%  4.68% 
Med-tech firms  21.43%  36.00%  6.23%  -6.05%  0.90% 
High-tech firms  52.94%  70.53%  2.55%  0.99%  5.21% 
Large firms           
Low-tech firms  63.16%  72.93%  2.96%  0.64%  2.27% 
Med-tech firms  66.67%  97.67%  7.30%  4.97%  6.67% 
High-tech firms  68.75%  91.80%  5.70%  5.25%  5.36% 
Notes: (1) Average cumulative annual rate. 
5. Decomposing R&D growth 
5.1. Methodology 
To examine how the intensive and extensive margins explain the evolution of R&D 
expenditure growth we first need to decompose R&D expenditure to capture the two 
dimensions we are interested in. Thus, for any year t we can write the total value of corporate 
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R&D expenditure for technological intensity group z ∈ Z (where Z is either high, medium and 
low tech groups) and for size group j ∈ J (where J is small and large)
13
     
 as: 
  
where Vzj,t is the value of total corporate R&D expenditure in year t for size group j and 
technological group z, nzj,t is the number of R&D spells, and vzj,t is the average value of R&D 
expenditure for each R&D spell in year t. R&D spells consist of those that survive from t−1 to 
t, denoted szj,t, and new spells, denoted ezj,t, so that we can write  . 
  Using the above notation, the increase in total R&D expenditure for size group j and 
technological intensity group z, from period t to t+1, can be written as: 
        (1) 
where + ,1 zj t s is the number of surviving spells from t to t+1,  + − ,1 , () zj t zj t vv  is the growth of R&D 
expenditure for each surviving spell,   is the number of R&D spells that fail in t, being 
 their total value in terms of R&D expenditure, and   is the number of new R&D 
spells, being   its total value in terms of R&D expenditure. 
  We aim to refine our decomposition for R&D growth in each technological intensity 
group z, considering that the probability of failure for an R&D spell in t may depend on the 
age of the spell (more specifically, we expect the probability of failure to be negatively related 
with the duration of the spell; i.e. negative duration dependence). To do so, we need to 
incorporate the age of the R&D spell into the decomposition. And second, we may estimate 
survival and hazard functions at the technological intensity group level. If we take into 
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where superscript i denotes the age of the spell (survival year), and hzj,t denotes the hazard rate 
for an R&D spell in size group j and technological intensity group z, ending between t-1 and t. 
As we have interval group data we assume that the minimum duration of the R&D spell is one 
year,  ≡
0
, 1 zj t s  (by extension  ≡≡
00
,, 1 and  1 zj t zj t dh ). The expression   denotes the number of 
R&D spells between t-1 and t that survive through the i
th year of uninterrupted performance of 
R&D.  
                                                 
13 Due to the sampling scheme of the ESEE (see data section) we carry our analysis for two size groups of firms: 
small firms (those with 10 to 200 employees) and large firms (those with more than 200 employees). 
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  Now, we can rewrite equation (1) as follows: 
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   (2) 
where  I  denotes the maximum potential length of an R&D spell;  + − ,1 (1 )
i
zj t h   gives the 
percentage of surviving R&D spells between t  and  t+1; and,  + − ,1 , (1 )
ii
zj t zj t hn gives the total 
number of surviving R&D spells between t and t+1 that correspond to firms performing R&D 
uninterruptedly for i years. Expression  +  −  ,1 ,
ii
zj t zj t vv represents the deepening or growth in 
R&D expenditures for surviving R&D spells;   gives the number of R&D spells that 
end in year t+1;   gives their total value; and,  gives the value of new R&D 
performers in year t+1. 
  If we sum equation (2) across the three technological intensity groups, we can 
decompose the variation in total manufacturing R&D expenditure for size group j in intensive 
and extensive margins: 
{ } + + + + + + ++
∈ ∈==
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  This equation is the decomposition of the growth of total R&D expenditures into 
extensive and intensive margins that we propose. The intensive margin is comprised of 
deepening and survival. Higher survival (lower hazard) results in more R&D spells (more 
continuing R&D spells and fewer failures). The final term captures the extensive margin. We 
would like to emphasize that it is crucial to account for the age of the R&D spell as we expect 
the probability of failure of an R&D spell to be higher at earlier stages (negative duration 
dependence).  
A further step to evaluate the importance of survival, deepening and entry to explain 
the growth of R&D expenditures, for each of the different technological intensity groups is to 
undertake counterfactual exercises. 
 
5.2. Counterfactuals exercises 
To assess the contribution of each of the R&D expenditure growth components we will carry 
out a series of counterfactual exercises. These will be performed by substituting each of the 
R&D growth components in equation (3) by a hypothetical firm or group of firms. In doing so 
we will be able to answer the question of what would have been the R&D growth 
performance of small (large) firms had they had other (hypothetical) experience in each of the 
components (either survival, deepening or entry). These exercises will allow us to assess the 
importance of each component on R&D growth. To analyse how the R&D growth of each 
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group of firms would change with counterfactual survival we would change the survival 
component in equation (3) by the counterfactual values, 
+ + + + ++
∈==
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where the superscript CF denotes the counterfactual values. Analogously, we can calculate 
the counterfactual deepening and entry effects, respectively, as follows: 
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  The decomposition of growth in each of the components allows us to evaluate how 
different the R&D of each group of firms would have been if it had had  the chosen 
(hypothetical) counterfactual survival, deepening and entry performance. 
6. Results 
In this section we present the decomposition of R&D growth, for small and large firms, in 
each of the components and the counterfactual results.  
 
6.1. Decomposition of R&D growth 
We start by analysing the decomposition of R&D growth by size group. In table 6 we report 
the percentage contribution of both the intensive and extensive margin to R&D growth. We 
also divide the intensive margin into its two components:  the contribution of survivors 
(survivors times deepening) and the contribution of the firms that fail to continue performing 
R&D.  
  For small firms we find that, as expected (see table 4), the extensive margin is the 
main driver of R&D growth (167.61%). And we find that the intensive has a negative 
contribution (-67.61%). If we analyse in detail the intensive margin we find that although the 
contribution of surviving small firms is important and positive (179.67%), the negative impact 
of the failures (-247.28%) more than compensates this contribution resulting in a negative 
contribution of the intensive margin. On the other hand, we find the opposite situation for 
large firms. In this case the main driver of R&D growth is the intensive margin (89.02%). 
This is consistent with the results obtained in table 4. Looking at the components of the 
intensive margin for large firms, we find a significant contribution of surviving firms 
(122.27%) that it is only reduced by a 33.24% due to firms that fail in performing R&D 
activities, resulting in a positive and significant contribution of the intensive margin 
(89.61%). Finally, the intensive margin only contributes with a 10.98%. 
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Table 6. Decomposition of R&D growth components, 1990-2005 
  Intensive margin (%) components 
   
  (Survival)x(deepening) 









         
Small firms  179.67%  -247.28%  -67.61%  167.61% 
Large firms  122.27%  -33.24%  89.02%  10.98% 
 
 
  In sum, the R&D behaviour of small firms is characterised by high rates of turnover 
and low persistence. Growth rates of R&D are explained mainly by the R&D spent by new 
performers; while the increase in R&D done by companies that continue doing R&D is more 
than compensated by the loss of those that fail. On the contrary, the R&D behaviour of large 
firms in the Spanish manufacturing sector is characterized by high persistence. The overall 
growth rate of large firms is explained mainly by the growth of R&D of continuous 
performers. 
 
6.2. Counterfactual exercises 
In this section we describe the counterfactual results obtained for each size group and 
technological sector. Before presenting the results we explain the hypothetical exercise we 
carry out in this research. We calculate the counterfactual results for each size group of firms 
(and for each technological sector) by increasing in a 5% either the survival, deepening or 
entry components (we also provide results increasing these components by a 10 and a 15%)
14
In table 7 we present the results from the 3 counterfactual exercises we have 
performed. For these three exercises we consider a specification where we allow each 
technological sector and size group hazard rate to vary by the spell length and starting year. In 
particular, we estimate a separate hazard function for each size and technological intensity 
group spell starting in every observed calendar year (e.g., a hazard function for each 
technological industry and size group for spells starting in 1990, 1991, etc.).
. 
The aim behind these exercises is to assess the importance of each component (for each group 
of firms) should we intended to increase the R&D growth rate. These results will help us in 
providing policy prescriptions to increase the R&D growth among Spanish manufacturing.  
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14 It is important to clarify that a 5% increase in the survival component is not equivalent to a 5% increase in the 
deepening or entry component. Therefore, it is meaningless to compare percentage increases across columns of 
table 7. 
 As mentioned 
above, we provide three exercises changing the percentage of increase for the three 
components to check if our results are robust. As we get almost lineal changes when changing 
15 By allowing the hazard rates to vary along these dimensions we can control for the fact that a size group 
and/or technological sector experiences changes in its hazard over calendar time. 
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the proportion of increase, we comment the results for the exercise where we increase the 
components by a 5%.  
 Table 7. Counterfactual exercises and R&D growth components 
    Increase of 5%  Increase of 10%  Increase of 15% 
 
Actual R&D 
growth  Survival Deepening Entry Survival Deepening Entry Survival Deepening Entry 
Total                     
Small firms  4.83%  0.41  0.87  0.27  0.78  1.63  0.54  1.25  2.32  0.79 
Large firms  11.71%  0.09  1.03  0.03  0.17  1.92  0.06  0.26  2.70  0.09 
Small firms                     
Low-tech  8.77%  0.44  1.25  0.32  0.82  2.29  0.62  1.21  3.18  0.92 
Med-tech  0.39%  0.79  1.63  0.56  1.51  2.93  1.07  2.14  4.00  1.54 
High-tech  6.29%  0.12  0.50  0.05  0.24  0.96  0.09  0.35  1.39  0.14 
Large firms                     
Low-tech  3.86%  0.17  0.47  0.20  0.33  0.90  0.39  0.48  1.3  0.58 
Med-tech  18.52%  0.09  1.16  0.01  0.18  2.14  0.02  0.26  2.99  0.03 
High-tech  1.89%  0.10  0.60  0.08  0.19  1.15  0.15  0.28  1.65  0.22 
 
In the first column, we present the actual average annual growth of R&D expenditure 
(in real terms) for each size group and technological sector, for the period 1990-2005. The 
following three columns report the average change in the R&D expenditure growth we would 
observe if each of the three components (survival, deepening and entry) of R&D growth 
experienced a hypothetical increase of 5%. In order to interpret the changes for each 
counterfactual we compare the percentage change in the R&D growth within each column. In 
particular and for the survival component, we find that a hypothetical increase in 5% in the 
survival rate would have a much larger impact on R&D growth for small than for large firms. 
The increase in R&D growth that small firms would experience is 0.41 percentage points 
(from 4.83% to 5.24%) whereas the increase for large firms would be 0.09 percentage points 
(from 11.71% to 11.80%). 
However, the increase in R&D growth is not homogeneous across technological 
sectors. Thus, the increase in R&D growth for small firms operating in med-tech industries is 
the largest (0.79 percentage points) and almost double what small firms operating in low-tech 
firms would experience (0.44 percentage points). Further, the increase in R&D growth for 
small firms operating in high-tech sectors is the lowest (0.12 percentage points). We also find 
heterogeneous results across technological sectors within large firms although the differences 
are smaller.
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16  We find (see section 4.2) that the survivor functions for large firms are not distinguishable across 
technological sectors as we cannot reject the H0 of equality of the three survivor functions. 
 We see that increasing the survival rate by a 5% (or equivalently by reducing 
the hazard rate by 5%) would have the largest impact on R&D growth (0.17 percentage 
points) for large firms operating in low-tech industries as compared to large firms operating in 
med and high-tech industries (0.09 and 0.10 percentage points, respectively). These results 
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help to clarify the relative impact of this component on R&D growth. From the above 
evidence we can conclude that survival is a much more important factor (about 4 times larger) 
for small firms R&D growth than for large firms, and this is especially important for small 
firms operating in med-tech (and in low-tech) industries. The above results are consistent with 
the descriptive evidence we presented in section 4: survival for small firms’ R&D spells is 
lower than the corresponding for large firms, being especially low the survival for small firms 
operating in low and med-tech industries.  
As regards the deepening component we observe that the increase in R&D growth, if 
there was a hypothetical increase in the deepening component of 5%, would be larger for 
large firms than for small firms, 1.03 and 0.87 percentage points, respectively. However, 
these aggregate figures hide a heterogeneous pattern across technological sectors. As regards 
to small firms, we observe that the increase in the deepening component would increase the 
R&D growth by 1.63 percentage points for firms operating in med-tech industries, by 1.25 
percentage points for firms in the low-tech industries and by only 0.50 percentage points for 
firms operating in high-tech industries.  
Thus, our results seem to suggest that deepening is an important factor for small firms 
whose activities are in med-tech (and also, to a lesser extent, for low-tech industries), but not 
for firms in high-tech industries. If we turn to large firms, we obtain a similar conclusion. The 
increase in R&D growth, if there was a 5% increase in the deepening component, would be 
1.16, 0.60 and 0.47 percentage points for firms operating in med, high and low-tech 
industries, respectively. Therefore, as previously, deepening turns out to be the most 
important component for firms operating in med-tech industries, regardless of their size, in 
order to increase the R&D growth.  
Finally, regarding the entry component, we observe that a hypothetical increase in the 
entry rate by 5% would increase the growth rate of R&D by 0.27 percentage points in small 
firms, while the average increase is nearly non significant in the case of large firms (0.03 
percentage points). Again, the impact of an increase in the entry rate is not uniform across 
technological sectors. Within small firms, those in the med-tech industry experience the 
largest change with an increase of 0.56 percentage points; followed by firms in the low-tech 
industry (0.32) and those in the high-tech are the ones experiencing the lowest impact (0.05). 
Regarding the impact in large firms, an increase in the entry rate by 5% would only have a 
significant impact in low-tech firms, which would see an increase in the R&D growth rate of 
0.20 percentage points. Therefore, and supporting the evidence found in the descriptive 
analysis, entry appears to be particularly important in small firms, or independently of size in 
med-tech industries. 
Additionally, in order to assess the relative importance of each component for R&D 
growth we carry out a numerical simulation exercise. In this exercise we would simulate how 
much should any component vary in order to achieve an increase in the average R&D growth 
of a one-percentage point. By performing these simulations we will be able to assess the 
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relative importance of each component for each group of firms and also across groups of 
firms. These results are reported in table 8.  
  We start by comparing large and small firms. For both groups of firms, the most 
effective target to reach an increase of a one-percentage point is the deepening component, 
being the required variations quite similar for both groups of firms. In other words, to increase 
the average R&D growth rate of small and large firms we would need to increase the amount 
of R&D spent by R&D performers (i.e. the deepening component) in 5.80% and 4.82% for 
small and large firms, respectively. However, we find remarkably differences in the other two 
components. Thus, whereas for small firms we would need either to increase the entry 
component by an 19.23%, or to reduce (increase) the hazard rate (survival) by 12.04%, these 
figures would be 186.77% and 51.47% for entry and survival, respectively, for large firms. 
This evidence points out that deepening is an important component, as compared to the other 
two components, for small firms but it reveals to be, by far, the most important component for 
large firms. This adds evidence to our descriptive analysis and indicates that survival for large 
firms is already high and in order to achieve a significant increase in R&D growth through 
this component a big effort would be needed. As regards to entry, we presented in our 
descriptive statistics that entry is very low for large firms (see table 4) and thus the increase in 
the number of large firms doing R&D should also be significant in order to make a 
contribution of one percentage point to R&D growth.  
  The results presented above are not uniform across technological sectors. Thus, for 
small firms, although deepening is the most important component to reach a one percentage 
increase in R&D growth in the three technological sectors, we find important differences in 
the other two components between small firms operating in low and med-tech sectors as 
compared to firms operating in high-tech sectors. In particular, the increase in entry and in 
survival should be much larger for small firms in high-tech sectors as compared to firms in 
low and med-tech sectors. Therefore, this points to the fact that deepening is comparatively 
the most important component for small firms operating in high-tech sectors. This is 
consistent with the descriptive evidence we presented in table 5 and indicates that high-tech 
small firms have a profile similar to large firms.  
  As regards to large firms, we find that the three components are quite similar for large 
firms in med and high-tech industries (except for the entry component for firms in med-tech 
sectors)
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17 This result is not highly reliable, as we do not have much entry in this sector along the period of analysis. 
: for both groups of firms deepening is by large the most important component, 
being especially important for med-tech industries. It is important in the sense that we would 
only require a modest increment in the deepening rate to attain the desired target. For large 
firms operating in low-tech industries we also find that deepening is the most important 
component but this does not differ significantly from the importance of the other two 
components: survival and entry. Therefore we can conclude that deepening is the most 
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important component to achieve an increase of a one-percentage point in R&D growth for 
large firms regardless of the sector in which they operate. 
Finally, we should stress that we have also calculated the change in the component 
dividing the whole period (1990-2005) into three sub-periods: 1990-1995, 1995-2000 and 
2000-2005. These results are reported in Appendix B. In general, the results are qualitatively 
similar to the ones obtained for the whole period, highlighting the importance of the 
deepening component. Nevertheless, some differences arise, thus as we approach later periods 
the efforts that companies have to make in terms of entry in order to attain one percentage 
point increase in R&D growth become larger.  




1 percentage  
point increase in 
R&D growth  Survival  Deepening  Entry 
Total           
Small firms  4.80%  5.80%  12.04%  5.80%  19.23% 
Large firms  11.71%  12.71%  51.47%  4.82%  186.77% 
Small firms           
Low-tech  8.77%  9.77%  12.26%  3.92%  16.47% 
Med-tech  0.39%  1.39%  6.47%  2.91%  9.35% 
High-tech  6.29%  7.29%  36.75%  10.40%  107.99% 
Large firms           
Low-tech  3.86%  4.86%  26.07%  11.24%  26.87% 
Med-tech  18.52%  19.52%  56.01%  4.25%  519.61%
(1) 
High-tech  1.89%  2.89%  51.96%  8.57%  73.64% 
Notes: (1) The result we obtain for large firms in med-tech industries is not very reliable, as we do not have 
much entry into R&D in this sector along the period of analysis. 
7. Conclusions 
The objective of this paper was to study the differences in the growth of corporate R&D 
expenditure in the Spanish manufacturing sector based on their performance at the extensive 
and intensive margin. To do so, we use firm level data on R&D expenditures for 
manufacturing firms over the period 1990-2005 drawn form the Encuesta sobre Estrategias 
Empresariales. We find firms differ in their R&D performance along each margin according 
to their size and technological group. Our results show the R&D behaviour of small firms is 
characterised by high rates of turnover and low persistence. Growth rates of R&D are 
explained mainly by the R&D spent by new performers; while the increase in R&D by log 
term performers is more than compensated by the loss of those that fail. On the contrary, the 
R&D behaviour of large firms in the Spanish manufacturing sector is characterized by high 
persistence. The overall growth rate of large firms is explained mainly by the growth of R&D 
of continuous performers. 
The counterfactual exercises reveal that small firms would have had significant higher 
R&D growth were they able to improve their performance with respect to the survival channel 
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of the intensive margin as well as the performance of the extensive margin. However, the high 
failure rate in R&D activities for small firms reveals that increases in the extensive margin in 
a given year will not contribute to the long run R&D growth, as these gains will disappear 
within few years. The results also show that large firms would be able to attain higher rates in 
the long term if they could deepen their actual R&D efforts, particularly in med tech 
industries.  
R&D activities are high on the policy agenda of governments at national, European 
and regional level. R&D expenditures in Spain have been clearly lower than the OECD and 
European average, and clearly the country is falling behind with regards to the Lisbon 
Agenda’s 2010 objective to assign 3 per cent of GDP to R&D efforts, with at least two-thirds 
coming from private investments. The results of the counterfactual and numerical simulation 
exercises allow us to draw some policy prescriptions in order to boost these activities. Firstly, 
our results confirm the need to designed oriented policy initiatives according to firm size and 
technological field. Secondly, we find that policy initiatives designed to improve the 
deepening component of R&D growth appear to be the most effective, as it is only required a 
modest increment in the deepening rate to attain the desired target. However, these will only 
have a short run effect in small firms. Unless small firms have the right incentive to persist 
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Table A1. Industrial technological intensity (NACE-93 two digits industrial classification) 
    Industry  Industrial technological intensity 
Beverages  Low 
Textiles and clothing  Low 
Leather and shoes  Low 
Timber  Low 
Paper industry  Low 
Printing and printing products  Low 
Non metallic mineral products  Low 
Metallic products  Low 
Furniture  Low 
Other manufacturing goods  Low 
   
Food and tobacco  Medium 
Rubber and plastic  Medium 
Metallurgy  Medium 
Machinery and mechanical equipment  Medium 
Motors and cars  Medium 
   
Chemical products  High 
Office machines  High 
Electric and electronic machinery and material  High 
Other transport equipment  High 






Numerical simulations for sub-periods 1990-1995, 1995-2000 and 2000-2005. 
 





1 percentage  
point increase in R&D 
growth  Survival  Deepening  Entry 
Total           
Small firms  3.62%  4.62%  7.04%  5.22%  6.90% 
Large firms  23.22%  24.22%  18.15%  2.31%  2.81% 
Small firms           
Low-tech  9.69%  10.69%  4.71%  3.96%  5.77% 
Med-tech  0.94%  1.94%  8.43%  4.49%  21.45% 
High-tech  2.93%  3.93%  16.27%  11.51%  9.08% 
Large firms           
Low-tech  7.09%  8.09%  24.99%  8.41%  19.29% 
Med-tech  40.55%  41.55%  22.03%  1.92%  219.76% 
High-tech  -0.11%  0.89%  14.69%  15.35%  - 
Note: There is no entry for large high-tech firms in this period. 
 





1 percentage  
point increase in R&D 
growth  Survival  Deepening  Entry 
Total           
Small firms  9.47%  10.47%  12.49%  10.09%  14.34% 
Large firms  6.18%  7.18%  35.77%  4.74%  122.58% 
Small firms           
Low-tech  12.38%  13.38%  9.64%  3.33%  11.88% 
Med-tech  7.66%  8.66%  8.21%  5.68%  9.38% 
High-tech  8.87%  9.87%  49.99%  12.23%  267.51% 
Large firms           
Low-tech  -3.14%  -2.14%  13.71%  15.90%  21.85% 
Med-tech  6.96%  7.96%  68.57%  4.09%  380.20% 
High-tech  5.82%  6.82%  69.85%  14.38%  31.91% 
Note: The result we obtain for small high-tech firms and large med-tech firms is not very reliable, as we do not have much 









1 percentage  
point increase in R&D 
growth  Survival  Deepening  Entry 
Total           
Small firms  -0.21%  0.79%  9.11%  13.72%  36.13% 
Large firms  1.82%  2.82%  23.96%  9.77%  360.17% 
Small firms           
Low-tech  1.30%  2.30%  7.14%  8.17%  60.86% 
Med-tech  -7.56%  -6.56%  4.93%  7.17%  11.64% 
High-tech  4.95%  5.95%  45.07%  11.82%  568.79% 
Large firms           
Low-tech  6.34%  7.34%  20.64%  11.43%  32.89% 
Med-tech  1.86%  2.86%  37.46%  9.91%  2600.96% 
High-tech  -0.75%  0.25%  24.99%  4.70%  188.20% 
Note: The result we obtain for small high-tech firms and large med-tech firms is not very reliable, as we do not have much 
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